Drugs / DC/tumor fusion vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00626860 | Jul 2000 → Jan 2002 | metastatic melanoma | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC/tumor fusion vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00626860 ↗ |
| Modality | Vaccine | “DC/tumor fusion vaccine” NCT00626860 ↗ |
| Route | Subcutaneous | “SC vaccinations administered to each patient” NCT00626860 ↗ |